Logo image of HBC.OL

HOFSETH BIOCARE ASA (HBC.OL) Stock Overview

OSL:HBC - NO0010598683 - Common Stock

1.795 NOK
+0.04 (+2.57%)
Last: 9/8/2025, 11:48:57 AM

HBC.OL Key Statistics, Chart & Performance

Key Statistics
52 Week High3.6
52 Week Low1.16
Market Cap709.17M
Shares395.08M
Float204.28M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.31
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO12-02 2011-12-02
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


HBC.OL short term performance overview.The bars show the price performance of HBC.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

HBC.OL long term performance overview.The bars show the price performance of HBC.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of HBC.OL is 1.795 NOK. In the past month the price increased by 1.13%. In the past year, price decreased by -4.52%.

HOFSETH BIOCARE ASA / HBC Daily stock chart

HBC.OL Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 20 319.75B
AMG.DE AMGEN INC 12.9 129.53B
GIS.DE GILEAD SCIENCES INC 14.8 121.55B
VX1.DE VERTEX PHARMACEUTICALS INC 23.26 86.34B
ARGX.BR ARGENX SE 87.74 39.68B
22UA.DE BIONTECH SE-ADR N/A 21.35B
IDP.DE BIOGEN INC 8.88 17.81B
0QF.DE MODERNA INC N/A 8.05B
1MRNA.MI MODERNA INC N/A 8.02B
1EXAS.MI EXACT SCIENCES CORP N/A 7.29B
ABVX.PA ABIVAX SA N/A 5.69B
1VKTX.MI VIKING THERAPEUTICS INC N/A 2.59B

About HBC.OL

Company Profile

HBC logo image Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Company Info

HOFSETH BIOCARE ASA

Kipervikgata 13

Alesund MORE OG ROMSDAL NO

Employees: 75

HBC Company Website

HBC Investor Relations

Phone: 4773102200

HOFSETH BIOCARE ASA / HBC.OL FAQ

What is the stock price of HOFSETH BIOCARE ASA today?

The current stock price of HBC.OL is 1.795 NOK. The price increased by 2.57% in the last trading session.


What is the ticker symbol for HOFSETH BIOCARE ASA stock?

The exchange symbol of HOFSETH BIOCARE ASA is HBC and it is listed on the Euronext Oslo exchange.


On which exchange is HBC.OL stock listed?

HBC.OL stock is listed on the Euronext Oslo exchange.


What is HOFSETH BIOCARE ASA worth?

HOFSETH BIOCARE ASA (HBC.OL) has a market capitalization of 709.17M NOK. This makes HBC.OL a Small Cap stock.


How many employees does HOFSETH BIOCARE ASA have?

HOFSETH BIOCARE ASA (HBC.OL) currently has 75 employees.


What are the support and resistance levels for HOFSETH BIOCARE ASA (HBC.OL) stock?

HOFSETH BIOCARE ASA (HBC.OL) has a support level at 1.75 and a resistance level at 1.8. Check the full technical report for a detailed analysis of HBC.OL support and resistance levels.


Should I buy HOFSETH BIOCARE ASA (HBC.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HOFSETH BIOCARE ASA (HBC.OL) stock pay dividends?

HBC.OL does not pay a dividend.


What is the Price/Earnings (PE) ratio of HOFSETH BIOCARE ASA (HBC.OL)?

HOFSETH BIOCARE ASA (HBC.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.31).


HBC.OL Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to HBC.OL. When comparing the yearly performance of all stocks, HBC.OL is a bad performer in the overall market: 80.17% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HBC.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to HBC.OL. HBC.OL has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HBC.OL Financial Highlights

Over the last trailing twelve months HBC.OL reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS decreased by -8.42% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.91%
ROE -208.67%
Debt/Equity 1.86
Chartmill High Growth Momentum
EPS Q2Q%18.95%
Sales Q2Q%37%
EPS 1Y (TTM)-8.42%
Revenue 1Y (TTM)17.81%

HBC.OL Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

HBC.OL Ownership

Ownership
Inst Owners37.62%
Ins Owners0.02%
Short Float %N/A
Short RatioN/A